| Calcium antagonists. Clinical use in the treatment of angina. | |
| | |
MedLine Citation:
|
PMID: 6339199 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Angina pectoris results from an imbalance between the oxygen supply and the oxygen needs of the myocardium. While the classic form of angina is usually caused by demands exceeding supply, a primary and transient decrease in coronary blood flow is more and more often recognised as an aetiological factor of myocardial ischaemia. Calcium antagonists, although new in cardiovascular therapeutics, are already recognised as the treatment of choice for some forms of angina and as useful therapeutic adjuncts in others. Few contraindications to their use exist. They are potent vasodilators and they can prevent the occurrence of coronary artery spasm responsible for the Prinzmetal's variant form of angina. They can also reduce coronary artery tone, which if high, can compromise flow through a narrowed coronary artery. Nifedipine, diltiazem and verapamil can also influence the various determinants of myocardial oxygen consumption to reduce myocardial oxygen needs. Their effects on heart rate, blood pressure and on the inotropic state of the left ventricle is, in vivo, the balance between their direct effects on the vascular wall and myocardial muscular cells and their indirect effects represented by the reflex physiological responses. Significant variations in these effects exist between the 3 calcium antagonists such that treatment can be individualised to a particular patient's needs. Precautions with their use as well as most of their side effects can be understood from a knowledge of their direct and indirect properties. Other pharmacological effects of these drugs include a regional redistribution of coronary blood flow, cardioprotection, delay in cell death and possibly in the progression of atherosclerosis. The clinical significance of these properties remains to be investigated. |
| | |
Authors:
|
P Théroux; Y Taeymans; D D Waters |
Related Documents
:
|
959969 - The effects of coronary vasodilatation on cardiac performance during endotoxin shock. 6291359 - Captopril in congestive heart failure: improved left ventricular function with decrease... 10369649 - Reduced oxygen tension during cardiopulmonary bypass limits myocardial damage in acute ... 215419 - The role of beta-adrenoceptors in coronary blood flow distribution in normal and ischem... 12357109 - Protect the heart in the intensive care unit--but how? 15210449 - Endocardial endothelium in the avascular frog heart: role for diffusion of no in contro... 6605459 - Characteristics of left ventricular thrombus resulting in perioperative embolism. a com... 20584069 - Echocardiographic determinants of the clinical condition in patients with a systemic ri... 18006459 - Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partia... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Drugs Volume: 25 ISSN: 0012-6667 ISO Abbreviation: Drugs Publication Date: 1983 Feb |
Date Detail:
|
Created Date: 1983-05-27 Completed Date: 1983-05-27 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7600076 Medline TA: Drugs Country: AUSTRALIA |
Other Details:
|
Languages: eng Pagination: 178-95 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angina Pectoris
/
diagnosis,
drug therapy*,
physiopathology Angina Pectoris, Variant / drug therapy Calcium Channel Blockers / therapeutic use* Humans |
| Chemical | |
Reg. No./Substance:
|
0/Calcium Channel Blockers |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Calcium antagonists. Clinical use in the treatment of systemic hypertension.
Next Document: Selective effects of portal blood diversion and glucagon on rat hepatocyte rates of S-phase entry an...